Kyle L. Kolaja

High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents

Junyi Ma, Liang Guo, Steve Fiene et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2011 · 793 citations · Full text

Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action

Brigitte Ganter, Stuart Tugendreich, Cecelia I. Pearson et al. · Journal of Biotechnology · 2005 · 286 citations

Drug Target, Engineering, Predictive Toxicology +15

Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes

Liang Guo, Rory Abrams, Joshua Babiarz et al. · Toxicological Sciences · 2011 · 272 citations · Full text

Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells

Faye Drawnel, Stefano Boccardo, Michael Prummer et al. · Cell Reports · 2014 · 239 citations · Full text

Induction of Cyp1a1 Is a Nonspecific Biomarker of Aryl Hydrocarbon Receptor Activation: Results of Large Scale Screening of Pharmaceuticals and Toxicants in Vivo and in Vitro

Wenyue Hu, Claudio Sorrentino, Michael S. Denison et al. · Molecular Pharmacology · 2007 · 217 citations